<style type="text/css"> .wpb_animate_when_almost_visible { opacity: 1; }</style> Enap catalog › Details for: Enhancing R&D in science-based industry :
Normal view MARC view ISBD view

Enhancing R&D in science-based industry : an optimal stopping model for drug discovery

By: ZHAO, Guozhen.
Contributor(s): CHEN, Wen.
Material type: materialTypeLabelArticlePublisher: Exeter, UK : Elsevier, November 2009International Journal of Project Management 27, 8, p. 754-764Abstract: Drug discovery is a process of science work full of exploration and complexity. Drug researchers face the dilemma of either working ‘forever’ to create a perfect drug or delivering a workable drug within an acceptable deadline to both save lives and make a profit. Specifically, in the compound screening and optimization stage, drug researchers must decide whether or not to stop the research and deliver the result for clinical testing. This paper proposes a model of optimal stopping time to help drug researchers make such decisions. It examines the decision strategies drug researchers should take through maximizing their objective function. The numerical examples given here show that this model is widely applicable. The model offers potential merits in terms of its ability to clarify drug researchers’ decision-making practices and helping managers maneuver through the jungle of science work.
Tags from this library: No tags from this library for this title. Log in to add tags.
    average rating: 0.0 (0 votes)
No physical items for this record

Drug discovery is a process of science work full of exploration and complexity. Drug researchers face the dilemma of either working ‘forever’ to create a perfect drug or delivering a workable drug within an acceptable deadline to both save lives and make a profit. Specifically, in the compound screening and optimization stage, drug researchers must decide whether or not to stop the research and deliver the result for clinical testing. This paper proposes a model of optimal stopping time to help drug researchers make such decisions. It examines the decision strategies drug researchers should take through maximizing their objective function. The numerical examples given here show that this model is widely applicable. The model offers potential merits in terms of its ability to clarify drug researchers’ decision-making practices and helping managers maneuver through the jungle of science work.

There are no comments for this item.

Log in to your account to post a comment.

Click on an image to view it in the image viewer

Escola Nacional de Administração Pública

Escola Nacional de Administração Pública

Endereço:

  • Biblioteca Graciliano Ramos
  • Funcionamento: segunda a sexta-feira, das 9h às 19h
  • +55 61 2020-3139 / biblioteca@enap.gov.br
  • SPO Área Especial 2-A
  • CEP 70610-900 - Brasília/DF
<
Acesso à Informação TRANSPARÊNCIA

Powered by Koha